Colleen
PSA almost undetectable, and testosterone at 7 (lowest reading).
Side effects of therapy:
Hot flushes
Not as strong 30 percent off)
Not really fatigued
Testicles feel softer
Dry skin
Labs really all normal excepting a small drop in rbc and hematocrit
Long term, who knows--worry about cardio and osteo

share charts https://airomedical.com/blogs/treatment-guides/what-is-better-actinium-radium-or-lutetium-for-prostate-cancer
The results of many clinical trials show the efficiency of Lu-177 treatment:
Increasing the 5-year survival rate by 30%;
Decreasing the risk of recurrence;
Improving the quality of life in 70% of patients.
The investigations in Ac-225 efficacy presented:
Lowering levels of an indicator of prostate cancer PSA in 80% of patients;
Decreasing of 50-80% of metastases;
Increasing the life expectancy.
The studies in Ra-223 showed:
Increasing average survival;
Decreasing risks of death by 30%;
Reducing pain and making the life quality higher.
We can say that the Lutetium-177, Actinium-225, and Radium-223 therapy significantly improve prostate cancer patients' condition. It makes a longer life expectancy because it is successful and does not cause significant harm.